AsiaBaseMetals
CVE:ABZAsiaBaseMetals Inc. focuses on the exploration and development of precious and base metals properties in Canada. It explores for gold, silver, zinc copper, cobalt, and lithium deposits. The company holds 100% interest in the Gnome project consisting of 1,996 hectares located in British Columbia. AsiaBaseMetals Inc. was incorporated in 2009 and is based in Vancouver, Canada.
Batero Gold
CVE:BATBatero Gold Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in Colombia. The company explores for gold, copper, silver, antimony, hydrargyrum, autonomous system, lead, zinc, and molybdenum deposits. It owns a 100% interest in the Batero-Quinchia project, which consists of 1,407 hectares tenement and one application for a concession contract of 155 hectares located in the municipality of Quinchia, Department of Risaralda, Colombia. The company was formerly known as Angus Resources Inc. and changed its name to Batero Gold Corp. in July 2010. Batero Gold Corp. was incorporated in 2008 and is headquartered in Toronto, Canada.
Core-Mark
NASDAQ:CORECore-Mark Holding Co., Inc. engages in distribution and marketing of consumer goods. It offers products, marketing programs, and technology solutions. It operates through United States, and Canada, and Corporate geographical segments. The company was founded in 1888 and is headquartered in South San Francisco, CA.
NovaBay Pharmaceuticals
NYSE:NBYNovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.